Funding sources No external funding.
CLINICAL AND LABORATORY INVESTIGATIONS
Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response
Version of Record online: 25 APR 2013
© 2013 The Authors. BJD © 2013 British Association of Dermatologists
British Journal of Dermatology
Volume 168, Issue 5, pages 990–998, May 2013
How to Cite
Baerveldt, E.M., Onderdijk, A.J., Kurek, D., Kant, M., Florencia, E.F., Ijpma, A.S., van der Spek, P.J., Bastiaans, J., Jansen, P.A., van Kilsdonk, J.W.J., Laman, J.D. and Prens, E.P. (2013), Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response. British Journal of Dermatology, 168: 990–998. doi: 10.1111/bjd.12175
Conflicts of interest None declared.
- Issue online: 25 APR 2013
- Version of Record online: 25 APR 2013
- Accepted manuscript online: 19 DEC 2012 09:36PM EST
- Accepted for publication 2 December 2012
Figure S1. Erythrocyte sedimentation rate (a) and leucocyte counts (b) during ustekinumab treatment.
Table S1. Self-reported prevention of new plaques and koebnerization under ustekinumab therapy.
|bjd12175_sm_tables1.docx||11K||Supporting info item|
|bjd12175_sm_supplementary-figs1.tif||86K||Supporting info item|
|bjd12175_sm_supplementary-tables1.doc||45K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.